In sync with the JP Morgan Health Care Conference, Recursion Pharmaceuticals has unveiled Phenom-Beta, a deep learning model designed to transform cell microscopy images into meaningful biological representations. “Phenom-Beta allows you to take images of human cells from a microscope or other sources and turn them into mathematical representations of biology,” said Chris Gibson, CEO of Recursion, in an NVIDIA-hosted call with journalists.
Hosted on the NVIDIA BioNeMo platform, Phenom-Beta is the company’s first in a potential series of foundation models for external use. The name “Phenom-Beta” references both “phenomenal” and “phenomics.” The scientist Steven A. Garan coined “phenomics” in 1996 to refer to the study of phenotypes, the observable characteristics or traits of an organism influenced by genetic predisposition and environmental factors.
Recursion bets the new frontier in phenomics could echo the rise of genomicsRead more